Itau Unibanco Holding S.A.’s West Pharmaceutical WST Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-629	Closed	-$155K	–	651
2022 Q3	$155K	Buy	+629	New	+$192K	0.01%	260
2020 Q2	–	Sell	-527	Closed	-$80K	–	444
2020 Q1	$80K	Sell	527 -1,090	-67%	-$168K	0.01%	154
2019 Q4	$243K	Buy	+1,617	New	+$235K	0.01%	185
2019 Q3	–	Sell	-3,603	Closed	-$451K	–	684
2019 Q2	$451K	Buy	3,603 +2,875	+395%	+$339K	0.02%	325
2019 Q1	$70K	Hold	728	–	–	﹤0.01%	484
2018 Q4	$70K	Buy	+728	New	+$79K	﹤0.01%	484
2017 Q4	–	Sell	-495	Closed	-$151K	–	652
2017 Q3	$151K	Buy	495 +335	+209%	+$30.3K	0.01%	482
2017 Q2	$15K	Sell	160 -30	-16%	-$2.76K	﹤0.01%	454
2017 Q1	$16K	Buy	+190	New	+$15.9K	﹤0.01%	465

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Itau Unibanco Holding S.A.'s WST Position: Q4 2022 in Review

Itau Unibanco Holding S.A. sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 629 shares — an estimated $155K sold.

Itau Unibanco Holding S.A. first reported a position in WST in Q1 2017 and held it in 9 quarters. The position peaked at $451K in Q2 2019. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

Itau Unibanco Holding S.A. reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 629 West Pharmaceutical shares in Q4 2022, an estimated $155K.
Itau Unibanco Holding S.A. first reported a position in West Pharmaceutical in Q1 2017 and held it in 9 quarters.
Itau Unibanco Holding S.A.'s West Pharmaceutical position peaked at $451K in Q2 2019.
637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2022, filed 9 Feb 2023.